Health Canada Standard Processing License Provides Advantage for Cannabis Extraction and Vertical Integration Biotech Investing
Isodiol International Inc. Announces Acquisition of Food Labs, Inc. and Strategic Investor Relationship with Toba Capital LLC Cannabis Investing News
Kalytera Provides Update on Phase 2 Clinical Study Evaluating CBD in Prevention of Acute GVHD Biotech Investing
Cardiol Therapeutics: A Leader in Research and Commercial Development of Pharmaceutical Cannabidiol Products and Targeted Therapies for Heart Failure and Cancer Pharmaceutical Investing
Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Golodirsen (SRP-4053) Life Science Investing
Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm Pharmaceutical Investing
Lexicon Pharmaceuticals Announces Topline Phase 1 Clinical Results for LX2761 in Diabetes Life Science Investing
Supernus Announces Positive Results from Phase III Study For SPN-812 in Adolescents with ADHD Life Science Investing
Apellis Pharmaceuticals Provides Update on Its Phase 3 Program for Patients with Geographic Atrophy Life Science Investing
Amicus Therapeutics Announces First Patient Dosed in Phase 3 PROPEL Pivotal Study of AT-GAA in Patients with Pompe Disease Life Science Investing
